Neurona Therapeutics

company

About

Neurona Therapeutics is a provider of cell-based medicines dealing with neurological disorders.

  • 51 - 100

Details

Last Funding Type
Grant
Last Funding Money Raised
$1.50M
Industries
Biotechnology,Health Care,Therapeutics
Founded date
Apr 1, 2008
Number Of Employee
51 - 100
Operating Status
Active

Neurona Therapeutics is a pre-clinical stage biotechnology company that was founded by four neuroscientists and stem cell pioneers at The University of California, San Francisco. They are focused on the discovery and development of cell-based therapies to treat intractable neurological disease. Its initial aim is to generate therapeutic compositions of a specific type of nerve cell (or neuron) for targeted delivery into the injured nervous system. Based on nearly two decades of research, they believe that particular subpopulations of neurons have the unique ability to integrate and repair dysregulated neural circuits. Its talented team of scientists, scientific advisors, and board directors is working to accelerate breakthrough treatments for patients with significant unmet medical needs.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$1.50M
Neurona Therapeutics has raised a total of $1.50M in funding over 2 rounds. Their latest funding was raised on Oct 1, 2018 from a Grant round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Oct 1, 2018 Grant $1.50M 1 National Institutes of Health Detail

Investors

Number of Lead Investors
Number of Investors
1
1
Neurona Therapeutics is funded by 1 investors. National Institutes of Health are the most recent investors.
Investor Name Lead Investor Funding Round
National Institutes of Health Yes Grant